Fundraising FoxLumoptik
Washington Island, US · Delaware corporation · 2 known investors
Find your way into Lumoptik
Sign up to find every way you can get introduced to Lumoptik
- Your email: who you already know at Lumoptik, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Lumoptik team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Bright Point Medical develops the BrightPoint needle guidance system, which uses fiber optic light-reflectance sensing to give physicians real-time visual confirmation of tissue at the needle tip during spinal epidural procedures. The device is intended for use in childbirth epidurals, surgical anesthesia, joint injections, and pain management, serving anesthesiologists and other clinicians.
Founders & leadership
DV
Don VerleeMr. Verlee serves as Chief Scientific Officer of the issuer.
JL
Jonathan LambExecutive
FL
Frank LymanNamed on SEC filing
TJ
Thomas JanickiNamed on SEC filing
AA
Andy AlexanderNamed on SEC filing
Board
AJ
Arthur JanickiMr. Janicki serves as a director of the issuer.
JE
Jeff EnslinMr. Enslin serves as a director of the issuer.
BK
Brian KearnsBoard director
NO
Nicole O'RourkeBoard director
AH
Alexander HoltBoard director
CH
Cole HatfieldBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$2.5M disclosed across 3 rounds · 2019–2026
▶$1.5MraisedSep 2026 · 73 investors · Other Health CareRule 506(b)
▶$1.5MraisedSep 2026 · 73 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan LambExecutive Officer
- Jeff EnslinDirector
- Brian KearnsDirector
- Nicole O'RourkeDirector
- Alexander HoltDirector
- Cole HatfieldDirector
- Offering amount
- $2.3M
- Amount sold
- $1.5M
- Proceeds to insiders
- $64.5K
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$900KraisedNov 2021 · 29 investors · Other Health CareRule 506(b)
▶$900KraisedNov 2021 · 29 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Cole HatfieldExecutive Officer
- Kurtz SanfordDirector
- Frank LymanExecutive Officer, Director
- Thomas JanickiDirector
- Don VerleeExecutive Officer
- Schumann RobertDirector
- Brian KearnsDirector
- Jeff EnslinDirector
- Andy AlexanderExecutive Officer
- Offering amount
- $1.5M
- Amount sold
- $900K
- Minimum investment
- $10K
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$100KraisedJun 2019 · 2 investors · Other Health CareRule 506(b)
▶$100KraisedJun 2019 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Frank LymanExecutive Officer, Director
- Thomas JanickiDirector
- Jeff EnslinDirector
- Andy AlexanderExecutive Officer
- Arthur JanickiDirector
- Don VerleeExecutive Officer
- Offering amount
- $1.5M
- Amount sold
- $100K
- Minimum investment
- $25K
- Sales commissions
- $105K
- Placement agents
- Cova Capital Partners
- First sale
- May 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Lumoptik do?
- Bright Point Medical develops the BrightPoint needle guidance system, which uses fiber optic light-reflectance sensing to give physicians real-time visual confirmation of tissue at the needle tip during spinal epidural procedures. The device is intended for use in childbirth epidurals, surgical anesthesia, joint injections, and pain management, serving anesthesiologists and other clinicians.
- Who are Lumoptik's investors?
- Lumoptik's investors include Beresford Ventures, Berkeley Angel Network.
- How much funding has Lumoptik raised?
- Lumoptik has disclosed $2.5M raised across 3 rounds.
- Where is Lumoptik headquartered?
- Lumoptik is headquartered in Washington Island, US.